HKSH Medical Group Named Asia’s first Photon-Counting CT Simulator Reference Site, Bringing Global Impacts on Precision Medicine and Medical Imaging with Siemens Healthineers
HONG KONG, May 12, 2026 /PRNewswire/ -- HKSH Medical Group (HKSH) and global medical technology leader Siemens Healthineers today signed a collaboration agreement at the "Asia Summit on Global Health", establishing HKSH as Siemens Healthineers' first Photon‑Counting Computed Tomography Simulator (PCCT‑Sim) Reference Site in Asia. For driving the development of PCCT-Sim technology, HKSH is not only Siemens Healthineers' research...
The Future of Surgical Robotics: Exploring Advanced Supply Chains and Manufacturing at 2026 Medtec
SHANGHAI, May 12, 2026 /PRNewswire/ -- In 2026, the surgical robotics industry continues to grow steadily. Recent reports show that both procedure volumes and system deployments are rising consistently. Intuitive Surgical surpassed expectations in its Q1 earnings, installing 431 da Vinci systems globally and generating $2.77 billion in revenue, a 23% increase year-on-year,. This reflects a broader trend: the...
BGI Genomics joins HGP2 Rare Disease Alliance to Close Rare Disease Care Gap in Asia-Pacific
KUALA LUMPUR, Malaysia, May 12, 2026 /PRNewswire/ -- The HGP2 Rare Disease Alliance of the Asia-Pacific Region (HGP2 RaDiAnce–APAC) was officially launched in Kuala Lumpur on May 10. YBhg. Datuk Dr. Nor Fariza Binti Ngah, Deputy Director-General of Health (Research and Technical Support) at the Ministry of Health of Malaysia, and Hou Yong, General Manager of BGI Genomics, joined leading...
TEDxSugar Hill 2026 Announces Yosi Amram: Beyond IQ and EQ — The Rise of Spiritual Intelligence
SUGAR HILL, Ga., May 12, 2026 /PRNewswire/ -- Nearly three decades ago, national headlines told a dramatic story: "Individual Inc.'s CEO, Amram, Takes Leave, and Stock Drops." — Wall Street Journal"Founder of Individual takes leave and shares fall 37%." — The New York Times"Yosi Amram, the founder of Individual Inc., was fired as chief executive by his board." —...
DNA ‘barcodes’ help NUS researchers pinpoint gold nanoparticles that can strike cancer at its power source
A new high-throughput platform screens dozens of nanoparticle designs in living systems to identify those that reach tumour mitochondria, enabling more precise and effective cancer therapies SINGAPORE, May 12, 2026 /PRNewswire/ -- Researchers at the National University of Singapore (NUS) have developed a high-throughput method to identify gold nanoparticles capable of delivering therapies directly to mitochondria (the energy centres...
GIP Moves from Supporting Role to Key Variable: BrightGene Bio-Medical’s Phase III Results Signal Differentiation in Weight Loss Arena
SUZHOU, China, May 12, 2026 /PRNewswire/ -- As competition in the weight loss drug market progressively intensifies, the latest Phase III clinical data disclosed by BrightGene Bio-Medical (688166.SH) for BGM0504 has reignited market attention. Mean weight reduction of 19.3%, waist circumference decrease of 16.5 cm, systolic blood pressure reduction of 22.9 mmHg in the hypertensive population, alongside uric acid reduction...
Hengrui Pharma and Bristol Myers Squibb Announce Strategic Agreements to Advance Innovative Medicines Across Oncology, Hematology, and Immunology
Landmark collaboration leverages complementary capabilities to drive speed in early innovation and help advance medicines for patients worldwide Agreements include 13 programs with the potential to address significant unmet patient needs and support long‑term growth SHANGHAI and PRINCETON, N.J., May 12, 2026 /PRNewswire/ -- Hengrui Pharma ("Hengrui") (600276.SH; 01276.HK) and Bristol Myers Squibb ("BMS") today announced the companies have...
ScienceSoft Receives Frost & Sullivan’s 2025 North America Enabling Technology Leadership Recognition for Advancing Patient Engagement and Telehealth Innovation
ScienceSoft is recognized for enabling real-time patient engagement through AI-driven conversational technologies that streamline telehealth operations and enhance care delivery. SAN ANTONIO, May 12, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to announce that ScienceSoft has received the 2025 North America Enabling Technology Leadership Recognition in the patient engagement and telehealth industry for its outstanding achievements in innovation,...
NYSE Content Update: Eli Lilly to Celebrate 150 Years of Scientific Innovation
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, May 11, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Behind...
Ranok Therapeutics Announces the Publication of Positive Phase 1a Clinical Results for KRAS G12D Inhibitor RNK08954 in Cancer Discovery
BOSTON and HANGZHOU, China, May 11, 2026 /PRNewswire/ -- Ranok Therapeutics, a clinical-stage biotechnology company developing innovative therapies, today announced the publication of preliminary clinical results from its Phase 1a study of RNK08954 in the peer-reviewed journal Cancer Discovery. RNK08954 is a proprietary, highly selective, oral small-molecule inhibitor targeting KRAS G12D mutation in patients with advanced solid tumors. The study evaluated the...
